Unfractionated or Low–Molecular Weight Heparin for the Treatment of Cerebral Venous Thrombosis
Author(s) -
Jonathan M. Coutinho,
José M. Ferro,
Patrícia Canhão,
Fernando Barinagarrementería,
MarieGermaine Bousser,
J. Stam
Publication year - 2010
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.588822
Subject(s) - medicine , odds ratio , modified rankin scale , heparin , thrombosis , venous thrombosis , low molecular weight heparin , anticoagulant , univariate analysis , surgery , multivariate analysis , ischemia , ischemic stroke
There is no consensus whether to use unfractionated heparin or low-molecular weight heparin for the treatment of cerebral venous thrombosis. We examined the effect on clinical outcome of each type of heparin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom